NKT cells are activated by the specific glycolipid antigen α-galactosylceramide (α-GalCer) and proliferate and differentiate into two directions, IFN-γ-producing and IL-4-producing NKT cells, with the former anti-tumor and the latter pro-tumor [25]. The gene discussed is IFNG; the disease is neoplasm.